A study assessing copy number variations in the complement gene C4, which has so far not been associated with an attributable risk to AMD, suggests statistical significance for a protective association of increasing copy numbers of one C4 gene transcript (C4A) and AMD. This evidence concerns the gene C4A and age-related macular degeneration.